Skip to main content

Advertisement

SpringerLink
Log in

Cognitive changes in patients with Huntington’s disease (HD) and asymptomatic carriers of the HD mutation

A longitudinal follow–up study

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract.

Objective

Objective information about the onset and progression of cognitive impairment in Huntington’s disease (HD) is very important in the light of appropriate outcome measures when conducting clinical trials. Therefore, we evaluated the progression of cognitive functions in HD patients and asymptomatic carriers of the HD mutation (AC) over a 2.5–year period.We also sought to detect the earliest markers of cognitive impairment in AC.

Methods

A prospective study comparing HD patients, clinically asymptomatic HD mutation–carriers (AC) and non–carriers (NC). These groups were examined three times during a period of 2.5 years. At baseline the study sample consisted of 49 subjects. Forty–two subjects (19 HD patients, 12 AC and 11 NC) completed three assessments. A battery of neuropsychological tests measuring intelligence, attention, memory, language, visuospatial perception, and executive functions was performed.

Results

The performance of HD patients deteriorated on the following cognitive tests: Symbol Digit Modalities Test (SDMT), Stroop Colour and Word, Boston Naming Test (BNT), Object and Space Perception and Trail Making Test–B. Longitudinal comparison of AC and NC revealed that performances on SDMT, Block Span, Digit Span Backwards, Hopkins Verbal Learning Test (learning and delayed recall) and Conditional Associative Learning Test are impaired in AC.

Conclusions

Tasks measuring mainly attention, object and space perception and executive functions adequately assess the progression of HD disease. Other cognitive functions do not significantly deteriorate. Furthermore, problems in attention, working memory, verbal learning, verbal long–term memory and learning of random associations are the earliest cognitive manifestations in AC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bates G, Harper P, Jones L (2002) Huntington’s Disease. Third Edition.Oxford: Oxford University Press

  2. Bachoud-Levi AC, Maison P, Bartolomeo P, Boisse MF, Dalla Barba G, Ergis A, et al. (2001) Retest effects and cognitive decline in longitudinal follow- up of patients with early HD. Neurology 56:1052–1058

    CAS  PubMed  Google Scholar 

  3. Bamford KA, Caine ED, Kido DK, Cox C, Shoulson I (1995) A prospective evaluation of cognitive decline in early Huntington’s disease: functional and radiographic correlates. Neurology 45:1867–1873

    CAS  PubMed  Google Scholar 

  4. Ho AK, Sahakian BJ, Robbins TW, Barker RA, Rosser AE, Hodges JR (2002) Verbal fluency in Huntington’s disease: a longitudinal analysis of phonemic and semantic clustering and switching. Neuropsychologia 40:1277–1284

    Article  PubMed  Google Scholar 

  5. Hodges JR, Salmon DP, Butters N (1990) Differential impairment of semantic and episodic memory in Alzheimer’s and Huntington’s diseases: a controlled prospective study. J Neurol Neurosurg Psychiatry 53:1089–1095

    CAS  PubMed  Google Scholar 

  6. Kirkwood SC, Su JL, Conneally P, Foroud T (2001) Progression of symptoms in the early and middle stages of Huntington disease. Arch Neurol 58:273–278

    Article  CAS  PubMed  Google Scholar 

  7. Snowden J, Craufurd D, Griffiths H, Thompson J, Neary D (2001) Longitudinal evaluation of cognitive disorder in Huntington’s disease. J Int Neuropsychol Soc 7:33–44

    CAS  PubMed  Google Scholar 

  8. Paulsen JS, Zhao H, Stout JC, Brinkman RR, Guttman M, Ross CA, Como P,Manning C, Hayden MR, Shoulson I (2001) Clinical markers of early disease in persons near onset of Huntington’s disease. Neurology 57:658–662

    PubMed  Google Scholar 

  9. Rich JB, Troyer AK, Bylsma FW, Brandt J (1999) Longitudinal analysis of phonemic clustering and switching during word-list generation in Huntington’s disease. Neuropsychology 13:525–531

    Article  CAS  PubMed  Google Scholar 

  10. Campodonico JR, Codori AM, Brandt J (1996) Neuropsychological stability over two years in asymptomatic carriers of the Huntington’s disease mutation. J Neurol Neurosurg Psychiatry 61:621–624

    CAS  PubMed  Google Scholar 

  11. Giordani B, Berent S, Boivin MJ, Penney JB, Lehtinen S, Markel DS, et al. (1995) Longitudinal neuropsychological and genetic linkage analysis of persons at risk for Huntington’s disease. Arch Neurol 52:59–64

    CAS  PubMed  Google Scholar 

  12. Kirkwood SC, Siemers E, Stout JC, Hodes ME, Conneally PM, Christian JC, et al. (1999) Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers. Arch Neurol 56:563–568

    Article  CAS  PubMed  Google Scholar 

  13. Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R (2002) Longitudinal study evaluating neuropsychological changes in socalled asymptomatic carriers of the Huntington’s disease mutation after 1 year. Acta Neurol Scand 106:131–141

    Article  CAS  PubMed  Google Scholar 

  14. Witjes-Ane MN, Vegter-van der Vlis M, van Vugt JP, Lanser JB, Hermans J, Zwinderman AH, van Ommen GJ, Roos RA (2003) Cognitive and motor functioning in gene carriers for Huntington’s disease: a baseline study. J Neuropsychiatry Clin Neurosci 15:7–16

    PubMed  Google Scholar 

  15. Baro F (1973) A neuropsychological approach to early detection of Huntington’s chorea. Adv Neurol 1:1329–1338

    Google Scholar 

  16. Blackmore L, Simpson SA, Crawford JR (1995) Cognitive performance in UK sample of presymptomatic people carrying the gene for Huntington’s disease. J Med Genet 32:358–362

    CAS  PubMed  Google Scholar 

  17. Bradshaw JL, Phillips JG, Dennis C, Attingley JB, Andrews D, Chiu E, et al. (1992) Initiation and execution of movement sequences in those suffering from and at-risk of developing Huntington’s disease. J Clin Exp Neuropsychol 14:179–192

    CAS  PubMed  Google Scholar 

  18. de Boo GM, Tibben A, Lanser JB, Jennekens-Schinkel A, Hermans J, Maat-Kievit A, et al. (1997) Early cognitive and motor symptoms in identified carriers of the gene for Huntington disease. Arch Neurol 54:1353–1357

    CAS  PubMed  Google Scholar 

  19. de Boo GM, Tibben A, Lanser JB, Jennekens- Schinkel A, Hermans J, Vegtervan der Vlis M, et al. (1997) Intelligence indices in people with a high/low risk for developing Huntington’s disease. J Med Genet 34:564–568

    CAS  PubMed  Google Scholar 

  20. de Boo GM, Tibben AA, Hermans JA, Jennekens-Schinkel A, Maat-Kievit A, Roos RA (1999) Memory and learning are not impaired in presymptomatic individuals with an increased risk of Huntington’s disease. J Clin Exp Neuropsychol 21:831–836

    Article  CAS  PubMed  Google Scholar 

  21. Diamond R, White RF, Myers RH, Mastromauro C, Koroshetz WJ, Butters N, et al. (1992) Evidence of presymptomatic cognitive decline in Huntington’s disease. J Clin Exp Neuropsychol 14:961–975

    CAS  PubMed  Google Scholar 

  22. Foroud T, Siemers E, Kleindorfer D, Bill DJ, Hodes ME, Norton JA, et al. (1995) Cognitive scores in carriers of Huntington’s disease gene compared to noncarriers. Ann Neurol 37:657–664

    CAS  PubMed  Google Scholar 

  23. Gomez-Tortosa E, del Barrio A, Barroso T, Garcia Ruiz PJ (1996) Visual processing disorders in patients with Huntington’s disease and asymptomatic carriers. J Neurol 243:286–292

    CAS  PubMed  Google Scholar 

  24. Hahn-Barma V, Deweer B, Durr A, Dode C, Feingold J, Pillon B, et al. (1998) Are cognitive changes the first symptoms of Huntington’s disease? A study of gene carriers. J Neurol Neurosurg Psychiatry 64:172–177

    CAS  PubMed  Google Scholar 

  25. Jason GW, Pajurkova EM, Suchowersky O, Hewitt J, Hilbert C, Reed J, et al. (1988) Presymptomatic neuropsychological impairment in Huntington’s disease. Arch Neurol 45:769–773

    CAS  PubMed  Google Scholar 

  26. Jason GW, Suchowersky O, Pajurkova EM, Graham L, Klimek ML, Garber AT, et al. (1997) Cognitive manifestations of Huntington disease in relation to genetic structure and clinical onset. Arch Neurol 54:1081–1088 942

    PubMed  Google Scholar 

  27. Josiassen RC, Curry LM, Mancall EL (1983) Development of neuropsychological deficits in Huntington’s disease. Arch Neurol 40:791–796

    CAS  PubMed  Google Scholar 

  28. Kirkwood SC, Siemers E, Bond C, Conneally PM, Christian JC, Foroud T (2000) Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene. Arch Neurol 57:1040–1044

    Article  CAS  PubMed  Google Scholar 

  29. Lawrence AD, Hodges JR, Rosser AE, Kershaw A, French-Constant C, Rubinsztein DC, et al. (1998) Evidence for specific cognitive deficits in preclinical Huntington’s disease. Brain 121: 1329–1341

    Article  PubMed  Google Scholar 

  30. Lundervold AJ, Reinvang I (1995) Variability in cognitive function among persons at high genetic risk of Huntington’s disease. Acta Neurol Scand 91:462–469

    CAS  PubMed  Google Scholar 

  31. Oepen G, Mohr U, Willmes K, Thoden U (1985) Huntington’s disease: visuomotor disturbance in patients and offspring. J Neurol Neurosurg Psychiatry 48:426–433

    Google Scholar 

  32. Rosenberg NK, Sorensen SA, Christensen AL (1995) Neuropsychological characteristics of Huntington’s disease carriers: a double blind study. J Med Genet 32:600–604

    CAS  Google Scholar 

  33. Rothlind JC, Brandt J, Zee D, Codori AM, Folstein S (1993) Unimpaired verbal memory and oculomotor control in asymptomatic adults with the genetic marker for Huntington’s disease. Arch Neurol 50:799–802

    PubMed  Google Scholar 

  34. Snowden JS, Craufurd D, Thompson J, Neary D (2002) Psychomotor executive and memory function in preclinical Huntington’s disease. J Clin Exp Neuropsychol 24:133–145

    Article  CAS  PubMed  Google Scholar 

  35. Strauss ME, Brandt J (1986) Attempt at preclinical identification of Huntington’s disease using the WAIS. J Clin Exp Neuropsychol 8:210–208

    CAS  PubMed  Google Scholar 

  36. Strauss ME, Brandt J (1990) Are there neuropsychologic manifestations of the gene for Huntington’s disease in asymptomatic at-risk individuals? Arch Neurol 47:905–908

    CAS  PubMed  Google Scholar 

  37. Witjes-Ané MN (2003) The evolution of cognitive,motor and behavioural characteristics in ‘presymptomatic’ carriers for Huntington’s disease-A prospective study. Leiden: Universiteit Leiden

  38. Georgiou-Karistianis N, Smith E, Bradshaw JL, Chua P, Lloyd J, Churchyard A, Chiu E (2003) Future directions in research with presymptomatic individuals carrying the gene for Huntington’s disease. Brain Res Bull 59:331–338

    Article  PubMed  Google Scholar 

  39. Huntington study group.Unified Huntington’s disease rating scale: reliability and consistency (1996) Huntington study group. Mov Disord 11:136–142

    Google Scholar 

  40. van der Ploeg HM, Defares PB Spielberger CD (1979) Handleiding bij de Zelf-BeoordelingsVragenlijst. Lisse: Swets en Zeitlinger

  41. Bouman TK, Luteijn F, Albersnagel FA, van der Ploeg FA (1985) Enige ervaringen met de Beck Depression Inventory. Gedrag – Tijdschrift Voor Psychologie 13:13–24

    Google Scholar 

  42. Quinn N, Brown R, Craufurd D, Goldman S, Hodges J, Kieburtz K, et al. (1996) Core assessment program for intracerebral transplantation in Huntington’s disease (capit-hd). Mov Disord 11:143–150

    CAS  PubMed  Google Scholar 

  43. Nelson HE (1982) National Adult Reading Test Manual. National Hospital London

  44. Schmand B, Lindeboom J, van Harskamp F (1992) Nederlandse leestest voor volwassenen. Lisse: Swets en Zeitlinger

  45. Stinissen J, Willems PJ, Coetsier P, Hulsman WL (1981) WAIS Dutch adaptation Wechsler Adult Intelligence Scale. Lisse, The Netherlands: Swets & Zeitlinger

  46. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198

    Google Scholar 

  47. Smith A (1982) Symbol Digit Modalities Test (SDMT) Manual (Revised). Los Angeles:Western Psychological Services

    Google Scholar 

  48. Stroop JR (1935) Studies of interference in serial verbal reaction. J Exp Psychology 18:643–662

    Google Scholar 

  49. Brandt J (1991) The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychol 5:125–141

    Google Scholar 

  50. Benedict RH, Schretlen D, Groninger L, Brandt J (1998) The Hopkins Verbal Learning Test – Revised: Normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol 12:43–55

    Article  Google Scholar 

  51. Wilson BA, Cockburn J, Baddeley A (1985) The Rivermead Behavioral Memory Test. Reading, England//Gaylord, MI: Thames Valley Test Co; National Rehabilitation Services

  52. Milner B (1971) Interhemispheric differences in the localization of psychological processes in man. Br Med Bull 27:272–277

    CAS  PubMed  Google Scholar 

  53. Kaplan EF, Goodglass H, Weintraub S (1983) The Boston Naming Test. Philadelphia: Lea&Febiger

  54. De Renzi E, Vignolo LA (1962) The Token test: a sensitive test to detect disturbances in aphasics. Brain 85:665–678

    CAS  PubMed  Google Scholar 

  55. Warrington EK, James M (1991) Visual Object and Space Perception Battery. Bury, St. Edmunds, Suffolk, England//Gaylord, MI: Thames Valley Test Co; National Rehabilitation Services

  56. Heaton RK, Chelune GJ, Talley JL,Kay Gary G, Curtiss G (1993) Wisconsin Card Sorting Test Manual: revised and expanded.Odessa: Psychological Assessment Resources, Inc

  57. Nelson HE (1976) A modified card sorting test sensitive to frontal lobe defects. Cortex 12:313–324

    CAS  PubMed  Google Scholar 

  58. Reitan RM (1958) Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 8:271–276

    Google Scholar 

  59. Spreen O, Strauss E (1991) A compendium of neuropsychological tests. New York: Oxford University Press

    Google Scholar 

  60. Petrides M, Milner B (1982) Deficits on subject-ordered tasks after frontaland temporal-lobe lesions in man. Neuropsychologia 20:249–262

    Google Scholar 

  61. Taylor AE, Saint-Cyr JA, Lang AE (1990) Memory and learning in early Parkinson’s disease: evidence for a “frontal lobe syndrome”. Brain Cogn 13:211–232

    CAS  PubMed  Google Scholar 

  62. Siesling S, van Vugt JP, Zwinderman KA, Kieburtz K, Roos RA (1998) Unified Huntington’s disease rating scale: a follow up. Mov Disord 13:915–919

    CAS  PubMed  Google Scholar 

  63. Starkstein SE, Brandt J, Folstein S, Strauss M, Berthier ML, Pearlson GD, et al. (1988) Neuropsychological and neuroradiological correlates in Huntington’s disease. J Neurol Neurosurg Psychiatry 51:1259–1263

    CAS  PubMed  Google Scholar 

  64. Bermel RA, Bakshi R, Tjoa C, Srinivas RP, Jacobs L (2002) Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. Arch Neurol 59:275–280

    Article  PubMed  Google Scholar 

  65. Cummings JL (1995) Anatomic and behavioral aspects of frontal-subcortical circuits. Ann N Y Acad Sci 769:1–13

    CAS  Google Scholar 

  66. Podoll K, Caspary P, Lange HW, Noth J (1988) Language functions in Huntington’s disease. Brain 111:1475–1503

    PubMed  Google Scholar 

  67. Hodges JR, Salmon DP, Butters N (1991) The nature of the naming deficit in Alzheimer’s and Huntington’s disease. Brain 114:1547–1558

    PubMed  Google Scholar 

  68. Butters N, Sax DS, Montgomery K, Tarlow S (1978) Comparison of the neuropsychological deficits associated with early and advanced Huntington’s disease. Arch Neurol 35:585–589

    CAS  PubMed  Google Scholar 

  69. Caine ED, Hunt RD, Weingarnter H, Ebert MH (1978) Huntington’s dementia. Clinical and neuropsychological features. Arch Gen Psychiatry 35:378–384

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Psychosocial Genetics Unit, Centre for Human Genetics, K. U. Leuven, Belgium

    M. Decruyenaere PhD & G. Evers-Kiebooms PhD

  2. Laboratory Neuropsychology, K. U. Leuven, Belgium

    E. Vandenbussche PhD

  3. Department of Neurology, UZ Gasthuisberg, Herestraat 49, 3000, Leuven, Belgium

    J. Lemiere MSc &  R. Dom

Authors
  1. J. Lemiere MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Decruyenaere PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Evers-Kiebooms PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Vandenbussche PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Dom
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Dom.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lemiere, J., Decruyenaere, M., Evers-Kiebooms, G. et al. Cognitive changes in patients with Huntington’s disease (HD) and asymptomatic carriers of the HD mutation. J Neurol 251, 935– 942 (2004). https://doi.org/10.1007/s00415-004-0461-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-004-0461-9

Key words

Search

Navigation